MEASUREMENT OF CANDIDA-SPECIFIC BLASTOGENESIS - COMPARISON OF CARBOXYFLUORESCEIN SUCCINIMIDYL ESTER LABELING OF T-CELLS, THYMIDINE INCORPORATION, AND CD69 EXPRESSION
R. Angulo et Da. Fulcher, MEASUREMENT OF CANDIDA-SPECIFIC BLASTOGENESIS - COMPARISON OF CARBOXYFLUORESCEIN SUCCINIMIDYL ESTER LABELING OF T-CELLS, THYMIDINE INCORPORATION, AND CD69 EXPRESSION, Cytometry, 34(3), 1998, pp. 143-151
Measurement of the T cell blastogenic response to Candida may be usefu
l in the evaluation of patients with suspected immunodeficiency, The c
lassic blastogenesis assay is based on uptake of [H-3]thymidine by per
ipheral blood lymphocytes stimulated with Candida antigens for 5 days.
An alternative approach involves staining peripheral blood lymphocyte
s with the intracellular fluorescent dye carboxyfluorescein succinimid
yl ester (CFSE) and measuring mitotic activity by the successive twofo
ld reductions in fluorescent intensity using flow cytometry (FCM), The
two approaches were compared in 16 subjects who demonstrated various
proliferative responses to Candida, FCM-derived indices all involved i
nitial gating on CD3(+) T cells and included 1) blastic transformation
as measured by changes in light scatter, 2) cell division, measured b
y CFSE fluorescence, and 3) CD69 expression. A good correlation was fo
und between [H-3]thymidine uptake and CFSE-derived indices, irrespecti
ve of the analysis algorithm used to interpret CFSE division profiles.
Furthermore, significant T cell proliferation occurred only in subjec
ts who had had one or more symptomatic episodes of vaginal candidiasis
whereas controls with no such history, and patients with chronic vagi
nal infection, showed minimal proliferation. The increase in proportio
n of CD69(+) T cells in culture also correlated with the blastogenic r
esponse to Candida, but less well than mitotic indices, CFSE-derived i
ndices of T cell blastogenesis to Candida are equivalent to [H-3]thymi
dine-based assays and may allow useful laboratory distinction between
subjects who have been exposed to and recovered from vaginal Candida i
nfection, who have a strong proliferative response, from those with no
exposure or chronic infection who demonstrate a poor response. (C) 19
98 Wiley-Liss, Inc.